tirzepatide approval date In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Eli Lilly's tirzepatide gained FDA

HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF) HFpEF is a syndrome characterized by symptoms of heart failure (e.g., dyspnea, fluid retention, fatigue) in patients with an ejection fraction of 45% or greater

L-Carnitine injections can benefit individuals looking to lose weight, improve their athletic performance, or enhance energy levels

Anyone with a chronic condition who takes medications on an ongoing basis knows that one of the most important things they need to do is look for medication interactions

Because GLP-1s impact the parts of the brain involved with reward, researchers began to wonder if they could reduce addictive behaviors